A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer.
about
Concepts and targets in triple-negative breast cancer: recent results and clinical implicationsGlucocorticoid receptor expression in 20 solid tumor types using immunohistochemistry assay.High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer.Recent advances in understanding glucocorticoid receptor function in cancer.
P2860
A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A randomized phase I trial of ...... ne for advanced breast cancer.
@en
A randomized phase I trial of ...... ne for advanced breast cancer.
@nl
type
label
A randomized phase I trial of ...... ne for advanced breast cancer.
@en
A randomized phase I trial of ...... ne for advanced breast cancer.
@nl
prefLabel
A randomized phase I trial of ...... ne for advanced breast cancer.
@en
A randomized phase I trial of ...... ne for advanced breast cancer.
@nl
P2093
P2860
P1433
P1476
A randomized phase I trial of ...... one for advanced breast cancer
@en
P2093
Bernadette Libao
Douglas E Merkel
Elias Obeid
Erica M Stringer-Reasor
Gini F Fleming
Jean Gibson
Mark J Ratain
Masha Kocherginsky
Maxwell Skor
Philip C Hoffman
P2860
P2888
P356
10.1186/S40064-016-2457-1
P577
2016-06-30T00:00:00Z
P6179
1034889652